hydroxyzine and tirzepatide Sublingual - An Overview Hydroxyzine with Ozempic: Drug Interaction

Averages reflect approximately 1,000 members on tirzepatide and 500 members on semaglutide who reported their weight on their intake questionnaire and on subsequent refill forms

Patients with depression history need careful monitoring

Br J Cancer 66:589593

Beyond Year One Maintenance phase: With continued treatment, metabolic improvements are typically maintained

GLP-1 medications may also interact with other medications a person is taking, which a doctor must take into account

Key findings from this 48-week, dose-ranging study of 338 adults with obesity: Participants receiving the highest dose (12 mg weekly) lost an average of 24.2% of their body weight in 48 weeks At the 12 mg dose, 100% of participants lost at least 5% of their body weight Approximately 83% of participants on the highest dose lost 15% or more of body weight The weight loss trajectory had not plateaued at 48 weeks, suggesting even greater weight loss with continued treatment To put these numbers in context, here is how retatrutides Phase 2 data compares to the landmark trials of existing medications: The fact that retatrutide achieved the highest percentage of weight loss in the shortest timeframe is what has researchers and patients so excited